Clinical trials: Fetal Presentation
Breech Presentation
Moxibustion for Fetus in Breech Presentation
Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting.
- Trial name
- NCT00890474
- Testing
- Moxibustion of the BL67 acupoint
- Where
- Switzerland
- Volunteers
- 212 people
- Sponsor
- University Hospital, Geneva
Fetus in Posterior or Transverse Position; Manual Rotation ; Obstetrics ; Delivery Room Practice
Evaluation of the Impact of Rotating Posterior and Transverse Presentations At 2 Hours of Full Dilation
During labor, 20% of fetuses present in a posterior or transverse position. Among them, 90% rotate spontaneously during labor. For the remaining 10%, maintaining a posterior or transverse position leads to longer labor, increased…
- Trial name
- NCT06886854
- Testing
- Mode of delivery
- Where
- 2 sites in France
- Volunteers
- 1,000 people
- Sponsor
- Hospices Civils de Lyon
Labor Onset and Length Abnormalities
Engagement of Fetal Head as a Predictor of a Successful Vaginal Delivery in Primigravidas Presented in Early Labor.
In primigravida, Delayed engagement of fetal head has been theorized that it is more likely in women with a possible cephalo-pelvic disproportion, so far they are associated with higher risk of cervical dystocia, which led to…
- Trial name
- NCT05084326
- Testing
- Engagement of fetal head as a predictor of a successful vaginal delivery
- Where
- Egypt
- Volunteers
- 226 people, healthy volunteers welcome
- Sponsor
- mohamed abosena
Neurological Development After Exposition to an Antenatal Nuchal Translucency
Follow up of Neurologic Development of Children Who Presented at the First Trimester of Pregnancy an Isolated Nuchal Anomaly With Normal Karyotype
Prospective, multicenter study following for 2 years, 250 children who presented during the first trimester of pregnancy an isolated nuchal translucency over the 95th percentile of Nicolaïdes Curves on ultrasound and comparing…
- Trial name
- EDEN (NCT02223936)
- Testing
- group exposed, Control
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon